Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
Y Jin, W Ji, H Yang, S Chen, W Zhang… - Signal transduction and …, 2020 - nature.com
On 12 March 2020, the outbreak of coronavirus disease 2019 (COVID-19) was declared a
pandemic by the World Health Organization. As of 4 August 2020, more than 18 million …
pandemic by the World Health Organization. As of 4 August 2020, more than 18 million …
[HTML][HTML] Withania somnifera (L.) Dunal: opportunity for clinical repurposing in COVID-19 management
A Saggam, K Limgaokar, S Borse… - Frontiers in …, 2021 - frontiersin.org
As the COVID-19 pandemic is progressing, the therapeutic gaps in conventional
management have highlighted the need for the integration of traditional knowledge systems …
management have highlighted the need for the integration of traditional knowledge systems …
Inflammatory mechanisms in COVID-19 and atherosclerosis: current pharmaceutical perspectives
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The …
coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The …
The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with …
Y Yang, Y Du, IA Kaltashov - Analytical chemistry, 2020 - ACS Publications
The emergence and rapid proliferation of the novel coronavirus (SARS-CoV-2) resulted in a
global pandemic, with over 6,000,000 cases and nearly 400,000 deaths reported worldwide …
global pandemic, with over 6,000,000 cases and nearly 400,000 deaths reported worldwide …
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
S Bellino - Annals of medicine, 2022 - Taylor & Francis
Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
The effects of high dose vitamin D supplementation as a nutritional intervention strategy on biochemical and inflammatory factors in adults with COVID-19: Study …
Z Khorasanchi, A Jafazadeh Esfehani… - Nutrition and …, 2022 - journals.sagepub.com
Introduction: Low serum vitamin D has been shown to be a risk factor for Coronavirus 2019
(COVID-19). The aim of this study was to assess the effects of high dose vitamin D …
(COVID-19). The aim of this study was to assess the effects of high dose vitamin D …
[HTML][HTML] Comparison of comorbidities in relation to critical conditions among coronavirus disease 2019 patients: a network meta-analysis
T Hoang, TTT Anh - Infection & Chemotherapy, 2021 - ncbi.nlm.nih.gov
Severe illness and poor outcome are mainly associated with aging or certain medical
comorbidities, especially chronic diseases. However, factors for unfavorable prognosis have …
comorbidities, especially chronic diseases. However, factors for unfavorable prognosis have …
[HTML][HTML] COVID-19 outbreak in Daegu City, Korea and response to COVID-19: how have we dealt and what are the lessons?
SW Kim - Journal of Korean Medical Science, 2022 - ncbi.nlm.nih.gov
The first coronavirus disease 2019 (COVID-19) outbreak in Daegu city was overcome by
efforts, including; 1) prompt isolation and quarantine action by local government with …
efforts, including; 1) prompt isolation and quarantine action by local government with …
[HTML][HTML] Where are we with understanding of COVID-19?
SM Akula, JA McCubrey - Advances in biological regulation, 2020 - Elsevier
Coronavirus disease 2019 caused by SARS-CoV-2 originated from China and spread
across every corner of the world. The scientific interest on COVID-19 increased after WHO …
across every corner of the world. The scientific interest on COVID-19 increased after WHO …
Risk Factors of Clonally Related, Multi, and Extensively Drug‐Resistant Acinetobacter baumannii in Severely Ill COVID‐19 Patients
MS Ahmed, ZFA Abdulrahman… - Canadian Journal of …, 2023 - Wiley Online Library
Background. The secondary infection of multi and extensively drug‐resistant “Acinetobacter
baumannii” in severely ill COVID‐19 individuals is usually associated with extended …
baumannii” in severely ill COVID‐19 individuals is usually associated with extended …